BioSyent, Inc. is a specialty pharmaceutical company, which engages in the development of pharmaceutical and healthcare products. The company is headquartered in Mississauga, Ontario. The Company, through its wholly owned subsidiaries, BioSyent Pharma Inc., and BioSyent Pharma International Inc., sources, acquires or in-licenses and further develops pharmaceutical and other healthcare products for sale in Canada and certain international markets. Hedley Technologies Ltd., a wholly owned subsidiary, operates the Company’s business marketing biologically and health friendly non-chemical insecticides. The Company’s products include Combogesic, Cathejell, FeraMAX Pd Therapeutic 150, FeraMAX Pd Maintenance 45, FeraMAX Pd Powder 15, Gelclair, Inofolic, Proktis-M, RepaGyn, and Tibella. Combogesic is for the short-term management of mild to moderate acute pain and the reduction of fever in adults. FeraMAX Pd Therapeutic 150 for the treatment of iron deficiency anemia. FeraMAX Pd Maintenance 45 is a chewable supplement with iron plus vitamin B12 and vitamin C for the prevention of iron deficiency anemia.
BioSyent Inc hisse başına yıllık % {var1} temettüye sahiptir ve % {var2} oranında bir getiri sunmaktadır. Temettü üç ayda bir ödenmektedir ve son temettü hariç tarihi Nov 28, 2025 tarihindedir.
Dividend Yield
Yıllık Dividende
Özsermaye Tarihi
0.00%
$0.15
Nov 28, 2025
Ödeme Sıklığı
Ödeme Oranı
Üç ayda bir
0.00%
Dividend History
Özsermaye Tarihi
Nakit Tutarı
Kayıt Tarihi
Ödeme Tarihi
Nov 28, 2025
$0.05
Nov 28, 2025
Dec 15, 2025
Aug 29, 2025
$0.05
Aug 29, 2025
Sep 15, 2025
May 30, 2025
$0.05
May 30, 2025
Jun 13, 2025
Feb 28, 2025
$0.05
Feb 28, 2025
Mar 14, 2025
Nov 29, 2024
$0.045
Nov 29, 2024
Dec 16, 2024
Sep 4, 2024
$0.045
Sep 4, 2024
Sep 15, 2024
Dividend Grafikleri
BIOYF Kâr Payları
BIOYF Dividend Growth (Yıllık Üstünlük)
Follow-Up Questions
BioSyent Inc'in şu anki temettü ödemesi ve yıllık temettüsü nedir?